Hemodialysis vascular access morbidity, J Am Soc Nephrol, vol.7, pp.523-535, 1996. ,
Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS), Nephrology Dialysis Transplantation, vol.19, issue.1, pp.108-120, 2004. ,
DOI : 10.1093/ndt/gfg483
Vascular access stenosis: Prospects for prevention and therapy, Kidney International, vol.49, issue.4, pp.1161-1174, 1996. ,
DOI : 10.1038/ki.1996.167
Stenosis and thrombosis in haemodialysis fistulae and grafts: the surgeon's point of view, Nephrology Dialysis Transplantation, vol.19, issue.2, pp.309-311, 2004. ,
DOI : 10.1093/ndt/gfg504
The treatment of vascular access graft dysfunction: a nephrologist's view and experience, Adv Ren Replace Ther, vol.1, pp.131-147, 1994. ,
Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment, Circulation, vol.80, issue.6, pp.1726-1736, 1989. ,
DOI : 10.1161/01.CIR.80.6.1726
Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts, Kidney International, vol.59, issue.6, pp.2325-2334, 2001. ,
DOI : 10.1046/j.1523-1755.2001.00750.x
Cell proliferation in human arteriovenous fistulas used for hemodialysis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.13, issue.4, pp.609-617, 1993. ,
DOI : 10.1161/01.ATV.13.4.609
The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature, vol.362, issue.6423, pp.801-809, 1993. ,
DOI : 10.1038/362801a0
Atherosclerosis and arteriosclerosis in chronic renal failure, Kidney International, vol.51, issue.6, pp.1678-1695, 1997. ,
DOI : 10.1038/ki.1997.233
Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis, Jama, vol.290, pp.353-359, 2003. ,
Oxidative stress in hemodialysis patients: Is NADPH oxidase complex the culprit?, Kidney International, vol.61, issue.80, pp.109-114, 2002. ,
DOI : 10.1046/j.1523-1755.61.s80.20.x
Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure, Kidney International, vol.56, issue.2, pp.383-392, 1999. ,
DOI : 10.1046/j.1523-1755.1999.00575.x
Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia, Kidney International, vol.63, issue.4, pp.1296-1301, 2003. ,
DOI : 10.1046/j.1523-1755.2003.00864.x
Hemodialysis Access Ultrasound, Ultrasound Quarterly, vol.17, issue.3, pp.157-167, 2001. ,
DOI : 10.1097/00013644-200109000-00003
Flow monitoring: performance characteristics of ultrasound dilution versus color Doppler ultrasound compared with fistulography, American Journal of Kidney Diseases, vol.42, issue.3, pp.539-545, 2003. ,
DOI : 10.1016/S0272-6386(03)00786-8
The role of surveillance in mature arteriovenous fistula management, Journal of Vascular Access, vol.5, pp.57-61, 2004. ,
A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts, Kidney International, vol.64, issue.1, pp.272-280, 2003. ,
DOI : 10.1046/j.1523-1755.2003.00070.x
Evidence of calcium phosphate depositions in stenotic arteriovenous fistulas, American Journal of Kidney Diseases, vol.38, issue.2, pp.377-383, 2001. ,
DOI : 10.1053/ajkd.2001.26104
Vascular calcification of the venous side of an arterious-venous fistula, Journal of Vascular Access, vol.2, pp.32-34, 2001. ,
Mouse Model of Venous Bypass Graft Arteriosclerosis, The American Journal of Pathology, vol.153, issue.4, pp.1301-1310, 1998. ,
DOI : 10.1016/S0002-9440(10)65675-1
The role of hyperparathyroidism, erythropoietin therapy, and CMV infection in the failure of arteriovenous fistula in hemodialysis, Kidney International, vol.64, issue.2, pp.715-719, 2003. ,
DOI : 10.1046/j.1523-1755.2003.00120.x
Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality, Nephrology Dialysis Transplantation, vol.18, issue.9, pp.1731-1740, 2003. ,
DOI : 10.1093/ndt/gfg414
Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density, Cell, vol.89, issue.2, pp.309-319, 1997. ,
DOI : 10.1016/S0092-8674(00)80209-3
Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation, Cell, vol.93, issue.2, pp.165-176, 1998. ,
DOI : 10.1016/S0092-8674(00)81569-X
Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease, Circulation, vol.109, issue.18, pp.2175-2180, 2004. ,
DOI : 10.1161/01.CIR.0000127957.43874.BB
C-reactive protein, inflammation, and coronary risk, Cardiology Clinics, vol.21, issue.3, pp.315-325, 2003. ,
DOI : 10.1016/S0733-8651(03)00079-1
C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients, American Journal of Kidney Diseases, vol.42, issue.2, pp.355-361, 2003. ,
DOI : 10.1016/S0272-6386(03)00675-9
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure Association of plasma fibrinogen concentration with vascular access failure in hemodialysis patients, Kidney Int Nephrol Dial Transplant, vol.55, issue.14, pp.1899-1911137, 1999. ,
Mineral metabolism parameters with respect to failure of arteriovenous fistula Vascular access Without failure With failure P No, p.109 ,
Inflammatory parameters with respect to failure of arteriovenous fistula Vascular access Without failure With failure P No, p.19 ,